Related News
Ebola vaccines to be ready next year
Print Edition
THOUSANDS of experimental Ebola vaccine doses from Britain’s GlaxoSmithKline and the United States’ NewLink should be ready for use by early next year, the World Health Organization said yesterday.
“If everything goes well, we might be able to begin using the vaccines in some of the affected countries at the very start of next year,” said WHO Assistant Director-general Marie-Paule Kieny.
There is no licensed treatment or vaccine against the virus that has killed nearly 3,000 people in West Africa, and the UN health agency has endorsed rushing through experimental treatments and vaccines.
WHO is especially focusing on two experimental vaccines, one by GSK and the other by NewLink Genetics, and is working with both companies to accelerate clinical trials, Kieny said.
Some clinical trials have begun in the US and others are set to begin in Mali next week, she said.
The agency has said that if found to be safe some doses should be available to health workers by November.
The Canadian government has donated 800 viles of the NewLink vaccine to the WHO, and Kieny said thousands more will likely be available soon.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
